Reid Huber Ph.D. — Chief Scientific Officer and Executive Vice President at Incyte Corporation

Dr. Reid M. Huber, Ph.D., has been the Chief Scientific Officer and Executive Vice President of Incyte Corporation since May 2014. Dr. Huber served as Senior Vice President of Discovery Biology at Incyte Corporation until April 2014. Dr. Huber leads drug discovery research primarily in the area of hematology/oncology. He was a founding member of the team that started drug discovery at Incyte Corporation in 2002. Dr. Huber joined Incyte in January 2002 as an Associate Director of Applied Technology. For nine years, he held roles of increasing responsibility in both drug discovery and clinical development at Incyte, as an Executive Director of Clinical Development. He began his career at DuPont Pharmaceuticals in 1998, where he held various positions until 2002. Dr. Huber has over 16 years of experience in pharmaceutical research and clinical development, in both senior leadership and scientific research positions. He held intramural pre-doctoral and post-doctoral fellowships at the National Institutes of Health from 1997 to 1998. He has been a Director of Bellicum Pharmaceuticals, Inc. since October 2014. Dr. Huber received his B.S. in biochemistry/molecular genetics from Murray State University and his Ph.D. in molecular genetics from Washington University.